Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-014116

Director acquired 5,622 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Postma Robert W Director 2026-01-12 Grant or award +5,622 $2.89 $16,248 43,872 D
Loading xslF345X05/ownership.xml…